STREPSURE Trademark

Trademark Overview


On Friday, March 1, 2024, a trademark application was filed for STREPSURE with the United States Patent and Trademark Office. The USPTO has given the STREPSURE trademark a serial number of 79393268. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 6, 2024. This trademark is owned by Nexsen Biotech Pty Ltd. The STREPSURE trademark is filed in the Medical Instrument Products category with the following description:

Apparatus for carrying-out diagnostic tests for detecting Group B Streptococcus (GBS) for medical purposes; diagnostic apparatus for medical purposes for testing Group B Streptococcus (GBS); diagnostic apparatus for medical purposes for testing for Group B Streptococcus (GBS); apparatus for carrying out diagnostic tests for medical purposes for testing for Group B Streptococcus (GBS); medical diagnostic apparatus for testing for Group B Streptococcus (GBS); testing instruments for medical diagnostic purposes for testing for Group B Streptococcus (GBS); sensors for medical use; sensors, namely, diagnostic apparatus for tresting for Group B Streptococcus (GBS); diagnostic testing apparatus for medical use for testing for Group B Streptococcus (GBS); diagnostic apparatus for use in medical analysis for testing for Group B Streptococcus (GBS); sensor apparatus for medical diagnosis, namely, patient monitoring sensors

General Information


Serial Number79393268
Word MarkSTREPSURE
Filing DateFriday, March 1, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesApparatus for carrying-out diagnostic tests for detecting Group B Streptococcus (GBS) for medical purposes; diagnostic apparatus for medical purposes for testing Group B Streptococcus (GBS); diagnostic apparatus for medical purposes for testing for Group B Streptococcus (GBS); apparatus for carrying out diagnostic tests for medical purposes for testing for Group B Streptococcus (GBS); medical diagnostic apparatus for testing for Group B Streptococcus (GBS); testing instruments for medical diagnostic purposes for testing for Group B Streptococcus (GBS); sensors for medical use; sensors, namely, diagnostic apparatus for tresting for Group B Streptococcus (GBS); diagnostic testing apparatus for medical use for testing for Group B Streptococcus (GBS); diagnostic apparatus for use in medical analysis for testing for Group B Streptococcus (GBS); sensor apparatus for medical diagnosis, namely, patient monitoring sensors
Translation of Words in MarkThe wording "STREPSURE" has no meaning in a foreign language.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 12, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNexsen Biotech Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, April 11, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 18, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, September 17, 2024ASSIGNED TO EXAMINER
Thursday, September 19, 2024NON-FINAL ACTION WRITTEN
Friday, September 20, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, October 12, 2024REFUSAL PROCESSED BY IB
Tuesday, October 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 20, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 20, 2024REFUSAL PROCESSED BY MPU